CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $197.94M, lower than 95% of all stocks globally
- PositionGross margin is 100%, higher than 95% of its Biotechnology peers (median 67.1%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
280.40BKRW197.94M · vs all stocks (USD)
Revenue (TTM)
10.92BKRW7.71M · vs all stocks (USD)
Profit Margin
-220.98%vs Biotechnology peers
Beta
-0.0190xvs all stocks
52-Week Change
-29.55%vs all stocks
Market Capitalization
280.40BKRW197.94M · vs all stocks (USD)
Enterprise Value
214.95BKRW151.73M · vs all stocks (USD)
Price to Sales (TTM)
25.68xvs Biotechnology peers
Price to Book (MRQ)
2.77xvs Biotechnology peers
Enterprise to Revenue
19.68xvs Biotechnology peers
Enterprise to EBITDA
-8.53xvs Biotechnology peers
Gross Margin
100.00%vs Biotechnology peers
Profit Margin
-220.98%vs Biotechnology peers
Operating Margin
-198.15%vs Biotechnology peers
Return on Assets (TTM)
-12.72%vs Biotechnology peers
Return on Equity (TTM)
-20.79%vs Biotechnology peers
Revenue (TTM)
10.92BKRW7.71M · vs all stocks (USD)
Revenue per Share (TTM)
79.15KRWUpdated Jul 15, 2026Quarterly Revenue Growth
146.40%vs Biotechnology peers
Gross Profit (TTM)
6.98BKRW4.93M · vs all stocks (USD)
EBITDA (TTM)
-25.20BKRW-17.79M · vs all stocks (USD)
Net Income (TTM)
-24.13BKRW-17.03M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
146.45%vs Biotechnology peers
Operating Cash Flow (TTM)
-22.90BKRW-16.16M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-19.78BKRW-13.97M · vs all stocks (USD)
Payout Ratio
0.00%vs Biotechnology peers
Revenue
9.23BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
3.94BKRWFY2025 · Dec 31, 2025Gross Profit
5.29BKRWFY2025 · Dec 31, 2025Operating Income
-26.32BKRW-18.58M · vs all stocks (USD)
Pre-tax Income
-23.88BKRWFY2025 · Dec 31, 2025Income Tax Expense
313.17MKRWFY2025 · Dec 31, 2025Net Income
-24.19BKRWFY2025 · Dec 31, 2025EBIT
-22.97BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
-21.54BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
21.11BKRWFY2025 · Dec 31, 2025Other Operating Expenses
730.85MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
3.32BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
903.40MKRWFY2025 · Dec 31, 2025EPS (Basic)
-175.00KRWFY2025 · Dec 31, 2025EPS (Diluted)
-175.00KRWFY2025 · Dec 31, 2025Basic Shares Outstanding
138.23MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
138.23MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-24.19BKRWFY2025 · Dec 31, 2025Operating Cash Flow
-24.56BKRWFY2025 · Dec 31, 2025Free Cash Flow
-24.81BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
5.28BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-24.19BKRWFY2025 · Dec 31, 2025Stock-based Compensation
288.94MKRWFY2025 · Dec 31, 2025Other Non-cash Items
-2.56BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-231.34MKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.13BKRWFY2025 · Dec 31, 2025Capital Expenditures
-246.32MKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-3.47BKRWFY2025 · Dec 31, 2025Net Acquisitions
-8.63BKRWFY2025 · Dec 31, 2025Purchase of Investments
-95.35BKRWFY2025 · Dec 31, 2025Sale of Investments
62.19BKRWFY2025 · Dec 31, 2025Other Investing Activity
37.58MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-41.99BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
1.00BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-10.34BKRWFY2025 · Dec 31, 2025Other Financing Charges
-22.33MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-7.56BKRWFY2025 · Dec 31, 2025Shares Outstanding
138.13MSharesUpdated Jul 15, 2026Float Shares
119.41MSharesUpdated Jul 15, 2026% Held by Insiders
15.82%vs all stocks
% Held by Institutions
0.34%vs all stocks
Total Cash (MRQ)
73.84BKRW52.12M · vs all stocks (USD)
Total Cash per Share (MRQ)
534.57KRWUpdated Jul 15, 2026Total Debt (MRQ)
2.17BKRW1.53M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0206xvs Biotechnology peers
Current Ratio (MRQ)
15.81xvs Biotechnology peers
Book Value per Share (MRQ)
762.25KRWUpdated Jul 15, 2026Total Assets
116.81BKRW82.46M · vs all stocks (USD)
Total Current Assets
82.78BKRWFY2025 · Dec 31, 2025Total Liabilities
6.69BKRWFY2025 · Dec 31, 2025Total Non-current Assets
34.03BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
1.65BKRWFY2025 · Dec 31, 2025Total Current Liabilities
5.04BKRWFY2025 · Dec 31, 2025Cash Equivalents
5.28BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
5.28BKRWFY2025 · Dec 31, 2025Other Short-term Investments
73.49BKRWFY2025 · Dec 31, 2025Accounts Receivable
1.05BKRWFY2025 · Dec 31, 2025Inventory
1.26BKRWFY2025 · Dec 31, 2025Accounts Payable
290.35MKRWFY2025 · Dec 31, 2025Short-term Debt
710.72MKRWFY2025 · Dec 31, 2025Other Current Liabilities
810.00KRWFY2025 · Dec 31, 2025Long-term Debt
1.55BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-90.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
69.06BKRWFY2025 · Dec 31, 2025Retained Earnings
-490.36BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
110.12BKRW77.74M · vs all stocks (USD)
52-Week Low
1.97KKRWUpdated Jul 15, 202652-Week High
5.40KKRWUpdated Jul 15, 202652-Week Change
-29.55%vs all stocks
Beta
-0.0190xvs all stocks
50-Day MA
2.76KKRWUpdated Jul 15, 2026200-Day MA
3.24KKRWUpdated Jul 15, 2026Avg 10-Day Volume
517.72KSharesUpdated Jul 15, 2026Avg 30-Day Volume
579.14KSharesUpdated Jul 15, 2026Diluted EPS (TTM)
-175.00KRWUpdated Jul 15, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 100%, higher than 95% of its Biotechnology peers (median 67.1%)Significant
Gross margin: 1.00Industry median: 0.67Industry P95: 1.00Peers compared: 261
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 1.00Profit Margin: -2.21
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 53.48
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $197.94M, lower than 95% of all stocks globallySignificant
Market cap (USD): 197,936,878.002Global P5: 269,387,740.27
Revenue is $7.71M, lower than 95% of all stocks globallySignificant
Revenue (USD): 7,708,288.13Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
ImmuneOncia Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Minerva Neurosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
RxSight Inc.
Tier 1ProductionApproval-Gated PipelineRule
Humedix Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
TaiGen Biopharmaceuticals Holdings Limited
Tier 1ProductionApproval-Gated PipelineRuleRisk
LENZ Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Camp4 Therapeutics Corp.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Onward Medical
Tier 1ProductionApproval-Gated PipelineRule
NextBioMedical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Voyager Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Upi Semiconductor Corp.
1 interpretationLow-Leverage Liquidity Configuration
Jiangsu Hengli Hydraulic Co., Ltd.
1 interpretationLow-Leverage Liquidity Configuration
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationLow-Leverage Liquidity Configuration